Why stated volumes mislead
Volumes in tenders are often indicative. Frameworks state maximum quantities, multi-partner awards split volume between suppliers, and some buyers publish no quantity at all. Planning production or pricing on the stated figure alone can be badly wrong in either direction.
Inputs for a better estimate
- The stated quantity and how the buyer describes it: estimate, maximum or commitment.
- Contract value divided by the unit price, where both are published.
- The volume of earlier rounds for the same buyer and molecule.
- The number of partners sharing the lot and how volume is split.
- Actual consumption of the molecule in that market.
Show estimates next to stated figures, never instead
An estimate is only useful if people know it is one. Keep stated and estimated volume in separate columns, say how each estimate was made, and only show averages where enough tenders stand behind them.
Questions
Are volumes in pharmaceutical tenders binding?
Usually not. Many tenders state estimated or maximum quantities, and multi-partner awards split volume between suppliers, so the volume a supplier actually delivers can differ widely from the stated figure.